Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Doxazosin Mesylate

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Doxazosin Mesylate Manufacturers in India Suppliers Doxazosin Mesylate Exporters Distributors Doxazosin Mesylate api active pharmaceuticals ingredients Doxazosin Mesylate manufacturers Side Effects bulk drugs raw material Doxazosin Mesylate companies Side Effects Importers Doxazosin Mesylate Doxazosin Mesylate Exporters Doxazosin Mesylate exporters FDA Doxazosin Mesylate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Doxazosin Mesylate manufacturing pharmaceutical drugs pharmaceutical intermediates Doxazosin Mesylate pharmaceutical chemicals pharmaceutical raw materials Doxazosin Mesylate active pharmaceutical ingredients Doxazosin Mesylate committee active pharmaceutical ingredients manufacturer Doxazosin Mesylate Active Pharmaceutical Ingredients manufacturer Doxazosin Mesylate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Doxazosin Mesylate, Doxazosin Mesylate manufacturer India, Doxazosin Mesylate product, Doxazosin Mesylate products, Api preparation, Certificate of Analysis API manufacturer product, Doxazosin Mesylate anti ulcer product, Certificate of Origin COA Doxazosin Mesylate COS Doxazosin Mesylate, pharmaceutical generic, pharmaceutical drug, medical, Doxazosin Mesylate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Doxazosin Mesylate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Doxazosin Mesylate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Doxazosin Mesylate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Doxazosin Mesylate ingredients, api, HIV Doxazosin Mesylate, tablets, capsules, syrup & protein Doxazosin Mesylate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Doxazosin Mesylate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Doxazosin Mesylate WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API
   Pharmaceuticals API List >>
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Pharmacokinetic data



 






 

 

HOME >> Pharmaceuticals API List 1 >> Doxazosin Mesylate >> Side Effects

Doxazosin Mesylate CAS number 74191-85-8

SIDE EFFECTS
Doxazosin Mesylate CAS number 74191-85-8

Dizziness, drowsiness, lightheadedness, headache, constipation, loss of appetite, dry mouth, tiredness, stuffy nose, blurred vision, dry eyes or trouble sleeping may occur the first several days as your body adjusts to the medication. If any of these effects continue or become bothersome, inform your doctor. Notify your doctor if you experience: chest pain, depression, swelling of hands or feet, sexual problems. Tell your doctor immediately if any of these highly unlikely but very serious side effects occur: persistent sore throat, fever, easy bleeding or bruising, nausea, stomach pain, yellowing eyes or skin, dark urine. Males - though it is unlikely to occur, if you get a painful, prolonged erection, stop using this drug and seek immediate medical attention. In the unlikely event you have a serious allergic reaction to this drug, seek immediate medical attention. Symptoms of a serious allergic reaction include: rash, itching, swelling, severe dizziness, trouble breathing.

Common reactions include dizziness, fatigue, headache, shortness of breath, diarrhea, abdominal pain, edema (fluid accumulation) and low blood pressure. Doxazosin causes significant reduction in blood pressure after administration of the first dose (first dose effect). This reduction in blood pressure may be associated with dizziness and fainting, especially when rising from a sitting position. To avoid this, patients should rise slowly from a sitting position, start treatment with the 1 mg dose, and then doses should be adjusted upwards slowly. Priapism (painful, prolonged penile erection) and a reduction in white blood cells have been associated with doxazosin.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS >>
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  


Taj pharmaceuticals API Logo

Doxazosin Mesylate

More Api at Taj Pharmaceuticals Ltd.

Alfuzosin

Oseltamivir Phosphate

 Amlodipine Besylate

Aripiprazole

Atorvastatin Calcium

Candesartan Cilaxetil

Cefdinir

Cetirizine Dihydrochloride

Ciprofloxacin HCl

Dextromethorphan Base

Diltiazem HCl

Domperidone Base

Domperidone Maleate

Doxazosin Mesylate

 Duloxetine HCl

Dutasteride

Enalapril Maleate

Esomeprazole Magnesium

Famotidine

Fexofenadine HCl

Fluconazole

Fluoxetine HCl

Galantamine HBr

Ibuprofen

Caffeine

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.